🟢 XBI is trading 3.07% up today as biotech IPOs raised $161.7 million

XBI is trading 3.07% up at $153.87, aligned with a broader biotech-sector rally.

• Lilly-backed TRex Bio and Retension Pharmaceuticals raised about $161.7 million combined in two biotech IPOs, adding to optimism about investor appetite for biotech listings.
• Sector sentiment is also supported by M&A and licensing activity, including a Novartis deal; these are sector-wide catalysts, not company-specific news about XBI.